Medicines
SmPC of 08/10/2009
WATER FOR INJECTION PREPARATIONS COOPER, injectable solution
Composition
Water for injections ................................................................................................................................q.s.
For one vial or one ampoule.
Indications
Extemporaneous dilution or dissolution of preparations intended for parenteral administration.
Dosage and administration
The posology and mode of administration depend on the products dissolved in water for injection preparations.
Warnings and precautions
Special warnings
As water for injection preparations is a hypotonic solution intended for the preparation of solutions for parenteral administration, it must not be injected alone.
Precautions for use
The mixture must be prepared extemporaneously with sterile equipment and under strict aseptic conditions.
Before use, check that the solution is clear.
For vials: before use, check the integrity of the closure and disinfect the stopper.
Interactions
Before dissolving a medicinal product, check its solubility and/or stability in water.
In the case of a mixture of several active substances, check their compatibility with one another.
Fertility, pregnancy and breastfeeding
The risks of use in pregnant or breastfeeding women are determined by the nature of the pharmaceutical products added.
Driving and using machines
The effects on the ability to drive vehicles and use machines are linked to the medicinal product(s) to be dissolved or diluted: refer to the package leaflet accompanying each medicinal product to be added.
Adverse effects
Intravenous injection of water for injection preparations may cause haemolysis if administered alone.
The nature of the additive will determine the possible occurrence of other adverse effects.
Overdose
Haemolysis may occur after infusion of large quantities of hypotonic solutions with water for injection preparations as diluent.
Signs and symptoms of overdose will also be related to the nature of the added medicinal products.
In case of accidental overdose, treatment must be interrupted and the patient must be monitored for signs and symptoms related to the medicinal products administered.
Preclinical safety
As water for injection preparations is only a vehicle for the administration of one or more pharmaceutical products, the preclinical safety data of the solution to be used will depend on the nature of the additive medicinal product.
Shelf life
Before opening:
- 3 years for glass vial presentations.
- 5 years for glass ampoule presentations.
After opening: the product must be used immediately.
Prescription, supply and reimbursement
| Marketing authorisation (AMM) |
|
PLACE LUCIEN AUVERT
77020 MELUN CEDEX
Tel: 01 64 87 20 00 https://www.cooper.fr/
Source: VIDAL · Updated on 10/11/2026. This information does not replace advice from a healthcare professional.
